Cargando…

Adverse event profiles of epidermal growth factor receptor‐tyrosine kinase inhibitors in cancer patients: A systematic review and meta‐analysis

ABSTRACT: The efficacy of agents targeting epidermal growth factor receptor (EGFR) in patients with various cancers was well elucidated. However, the safety profile of EGFR tyrosine kinase inhibitors (EGFR‐TKIs) has not been systematically investigated. This meta‐analysis aimed to evaluate the safet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Xiaonan, Zhao, Zhou, Yin, Yuan, Shen, Chaoyong, Chen, Xin, Cai, Zhaolun, Wang, Jian, Chen, Zhixin, Yin, Yiqiong, Zhang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212741/ https://www.ncbi.nlm.nih.gov/pubmed/33382906 http://dx.doi.org/10.1111/cts.12957

Ejemplares similares

Adverse events risk associated with regorafenib in the treatment of advanced solid tumors: meta-analysis of randomized controlled trials
por: Yin, Xiaonan, et al.
Publicado: (2018)

Optimal reconstruction methods after distal gastrectomy for gastric cancer: A systematic review and network meta-analysis
por: Cai, Zhaolun, et al.
Publicado: (2018)

Giant gastric stromal tumor mimicking as a posterior mediastinal mass: A case report and literature review
por: Yin, Xiaonan, et al.
Publicado: (2018)

Comparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal Cancer: A Network Meta-Analysis
por: Cai, Zhaolun, et al.
Publicado: (2018)

Impact of Surgical Margin Status on Survival in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Jiang, Zhiyuan, et al.
Publicado: (2021)

Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors
por: Shen, Chaoyong, et al.
Publicado: (2018)

Tenascin-C expression is significantly associated with the progression and prognosis in gastric GISTs
por: Shen, Chaoyong, et al.
Publicado: (2019)

Impact of surgical margin status on the survival outcome after surgical resection of gastric cancer: a protocol for systematic review and meta-analysis
por: Jiang, Zhiyuan, et al.
Publicado: (2020)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2019)

Comparative effectiveness of hyperthermic intraperitoneal chemotherapy for gastric cancer: A systematic review and network meta-analysis protocol
por: Cai, Zhaolun, et al.
Publicado: (2018)

Efficacy of liver transplantation for hilar cholangiocarcinoma: A protocol for a systematic review and meta-analysis
por: Cai, Zhaolun, et al.
Publicado: (2018)

Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
por: Huang, Jing, et al.
Publicado: (2020)

Clinicopathological features, clinical efficacy on 101 cases of rectal gastrointestinal stromal tumors, and the significance of neoadjuvant therapy
por: Yang, Hongxin, et al.
Publicado: (2021)

Pediatric pancreatic teratoma: A case report and literature review
por: Wang, Jian, et al.
Publicado: (2019)

Diffuse ileal ganglioneuromatosis mimicking a gastrointestinal stromal tumor: A case report
por: Yin, Xiaonan, et al.
Publicado: (2019)

Clinicopathological characteristics, treatment, and survival outcomes of retroperitoneal desmoid-type fibromatosis: A single-institution experience in China
por: Shen, Chaoyong, et al.
Publicado: (2019)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis
por: Wang, Jian, et al.
Publicado: (2020)

Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study
por: Shen, Chaoyong, et al.
Publicado: (2020)

Open and minimally invasive surgery for gastrointestinal stromal tumours: a systematic review and network meta-analysis protocol
por: Mu, Mingchun, et al.
Publicado: (2022)

Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis
por: Jiang, Zhiyuan, et al.
Publicado: (2021)

Adverse Reaction Profiles Related to Gastrointestinal Bleeding Events Associated with BCR-ABL Tyrosine Kinase Inhibitors
por: Kawada, Kei, et al.
Publicado: (2022)

Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems
por: Shen, Chaoyong, et al.
Publicado: (2016)

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia
por: Yoshifuji, Kota, et al.
Publicado: (2022)

Surgical resection for patients with recurrent or metastatic gastrointestinal stromal tumors: a protocol for a systematic review and meta-analysis update
por: Cai, Zhaolun, et al.
Publicado: (2021)

Integrated analysis of long non-coding RNAs and mRNAs associated with malignant transformation of gastrointestinal stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2021)

Meta-Analysis of Gastrointestinal Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
por: Mohanavelu, Prahathishree, et al.
Publicado: (2021)

Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors
por: Chen, Justin A., et al.
Publicado: (2020)

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK
por: Califano, R., et al.
Publicado: (2015)

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
por: Banno, Eri, et al.
Publicado: (2016)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
por: Tang, Sumin, et al.
Publicado: (2017)

Identification of gastrointestinal stromal tumors from leiomyomas in the esophagogastric junction: A single-center review of 136 cases
por: Yin, Xiaonan, et al.
Publicado: (2020)

Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance
por: Zhou, E., et al.
Publicado: (2022)

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
por: Tsai, Yuan-Chin, et al.
Publicado: (2018)

Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Chang, Youjin, et al.
Publicado: (2013)

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance
por: Heydt, Carina, et al.
Publicado: (2018)

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

Prospects for the future of epidermal growth factor receptor-tyrosine kinase inhibitors in combination with bevacizumab
por: Chikaishi, Yasuhiro, et al.
Publicado: (2020)

Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors
por: Yang, Sei-Hoon
Publicado: (2013)

Local excision and radical excision for rectal gastrointestinal stromal tumors: a meta-analysis protocol
por: Luo, Wenjun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1srag689fkbhf5palemv4cmd20